These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1932982)

  • 21. Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease.
    Baron TH; Richter JE; Singh S; Tennyson GS; Andres JM
    Am J Gastroenterol; 1993 Feb; 88(2):289-92. PubMed ID: 8424436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acid inhibitors for asthma patients].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
    Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
    Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
    Lauritsen K; Laursen LS; Madsen JR
    Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
    [No Abstract]   [Full Text] [Related]  

  • 25. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux.
    Moore DJ; Tao BS; Lines DR; Hirte C; Heddle ML; Davidson GP
    J Pediatr; 2003 Aug; 143(2):219-23. PubMed ID: 12970637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omeprazole and reflux oesophagitis.
    Kerr GD
    Aliment Pharmacol Ther; 1994 Apr; 8(2):263. PubMed ID: 8038359
    [No Abstract]   [Full Text] [Related]  

  • 27. [Successful treatment of severe reflux esophagitis with omeprazole: a therapeutic success?].
    Müller-Lissner S
    Z Gastroenterol; 1989 Feb; 27(2):131-2. PubMed ID: 2658391
    [No Abstract]   [Full Text] [Related]  

  • 28. [Retrosternal pain. Clinical conference about a subject with esophagitis].
    Loizeau E
    Rev Med Suisse Romande; 1993 Jul; 113(7):557-60. PubMed ID: 8367651
    [No Abstract]   [Full Text] [Related]  

  • 29. Optimal dose of omeprazole in infants and children.
    Alliët P; Raes M; Gillis P; Zimmermann A
    J Pediatr; 1994 Feb; 124(2):332-4. PubMed ID: 8301451
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gastroesophageal reflux disease].
    Lux G; Lederer PC
    Fortschr Med; 1990 Jun; 108(18):358-62. PubMed ID: 2198210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C
    Dig Liver Dis; 2005 Jul; 37(7):468-74. PubMed ID: 15893968
    [No Abstract]   [Full Text] [Related]  

  • 35. Current pharmacological treatment of reflux esophagitis.
    Pace F; Bollani S; Bianchi Porro G
    Hepatogastroenterology; 1998; 45(23):1316-27. PubMed ID: 9840060
    [No Abstract]   [Full Text] [Related]  

  • 36. [Internal medicine therapy in reflux disease].
    Flad J
    Praxis (Bern 1994); 1996 Nov; 85(45):1432-8. PubMed ID: 8975352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of diagnosis, mechanisms of development and the results of treatment of gastro-esophageal reflux and reflux esophagitis].
    Geller LI; Geller AL; Petrenko VF
    Ter Arkh; 1983; 55(2):89-92. PubMed ID: 6845207
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gastroesophageal reflux disease and reflux esophagitis. Therapeutic modifiability by bethanechol chloride].
    Hunold W
    ZFA (Stuttgart); 1982 Oct; 58(29):1623-8. PubMed ID: 6129755
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical treatment of reflux esophagitis.
    Olbe L; Lundell L
    Hepatogastroenterology; 1992 Aug; 39(4):322-4. PubMed ID: 1427576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.